The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Psychedelics as Medicines: An Emerging New Paradigm
Abstract
Scientific interest in serotonergic psychedelics (e.g., psilocybin and LSD; 5‐HT 2A receptor agonists) has dramatically increased within the last decade. Clinical studies administering psychedelics with psychotherapy have shown preliminary evidence of robust efficacy in treating anxiety and depression, as well as addiction to tobacco and alcohol. Moreover, recent research has suggested that these compounds have potential efficacy against inflammatory diseases through novel mechanisms, with potential advantages over existing antiinflammatory agents. We propose that psychedelics exert therapeutic effects for psychiatric disorders by acutely destabilizing local brain network hubs and global network connectivity via amplification of neuronal avalanches, providing the occasion for brain network “resetting” after the acute effects have resolved. Antiinflammatory effects may hold promise for efficacy in treatment of inflammation‐related nonpsychiatric as well as potentially for psychiatric disorders. Serotonergic psychedelics operate through unique mechanisms that show promising effects for a variety of intractable, debilitating, and lethal disorders, and should be rigorously researched.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dissociable intrinsic connectivity networks for salience processing and executive control
Seeley, W. W., Menon, V., Schatzberg, A. F., Keller, J., Glover, G. H., Kenna, H., Reiss, A. L., & Greicius, M. D. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.5587-06.2007 · Cited by 7,426
Neuronal Avalanches in Neocortical Circuits
Beggs, J. M., & Plenz, D. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-35-11167.2003 · Cited by 2,325
Drevets, W. C., Price, J. L., & Furey, M. L. (2008) · Brain Structure and Function · doi:10.1007/s00429-008-0189-x · Cited by 2,241
Griffiths, R. R., Johnson, M. W., Carducci, M. A., Umbricht, A., Richards, W. A., Richards, B. D., Cosimano, M. P., & Klinedinst, M. A. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116675513 · Cited by 2,201
Self-citationNichols, D. E. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.011478 · Cited by 1,762
Self-citationRoss, S., Bossis, A., Guss, J., Agin-Liebes, G., Malone, T., Cohen, B., Mennenga, S. E., Belser, A., Kalliontzi, K., Babb, J., et al. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116675512 · Cited by 1,698
Griffiths, R. R., Richards, W. A., McCann, U., & Jesse, R. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0457-5 · Cited by 1,684
Carhart-Harris, R. L., Bolstridge, M., Rucker, J., Day, C. M. J., Erritzoe, D., Kaelen, M., Bloomfield, M., Rickard, J. A., Forbes, B., Feilding, A., et al. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)30065-7 · Cited by 1,540
Modern network science of neurological disorders
Stam, C. J. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3801 · Cited by 1,307
Carhart-Harris, R. L., Leech, R., Hellyer, P. J., Shanahan, M., Feilding, A., Tagliazucchi, E., Chialvo, D. R., & Nutt, D. (2014) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2014.00020 · Cited by 1,252
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer
Grob, C. S., Danforth, A. L., Chopra, G. S., Hagerty, M., McKay, C. R., Halberstadt, A. L., & Greer, G. R. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.116 · Cited by 1,206 · cited 3×
“More recently, Grob et al.5 administered 0.2 mg/kg oral psilocybin vs. niacin placebo to 12 patients with advanced-stage cancer having a diagnosis of anxiety related to their cancer.”
InfluentialHuman hallucinogen research: guidelines for safety
Johnson, M., Richards, W., & Griffiths, R. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108093587 · Cited by 1,203
Self-citationSheline, Y. I., Price, J. L., Yan, Z., & Mintun, M. A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000446107 · Cited by 1,196
Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin
Carhart-Harris, R. L., Erritzoe, D., Williams, T., Stone, J. M., Reed, L. J., Colasanti, A., Tyacke, R. J., Leech, R., Malizia, A. L., Murphy, K., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1119598109 · Cited by 1,172
Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study
Bogenschutz, M. P., Forcehimes, A. A., Pommy, J. A., Wilcox, C. E., Barbosa, P., & Strassman, R. J. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114565144 · Cited by 1,151
Pilot study of the 5-HT 2A R agonist psilocybin in the treatment of tobacco addiction
Johnson, M. W., Garcia-Romeu, A., Cosimano, M. P., & Griffiths, R. R. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114548296 · Cited by 914 · cited 1×
“The first modern laboratory study examining a serotonergic psychedelic for addiction was an open-label pilot study that employed psilocybin with manualized cognitive behavioral therapy in 15 treatment-resistant tobacco/nicotine-dependent smokers, conducted by one of the present authors and colleagues.(19) After four p…”
BackgroundSelf-citationGriffiths, R., Richards, W., Johnson, M., McCann, U., & Jesse, R. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108094300 · Cited by 905
Self-citationMacLean, K. A., Johnson, M. W., & Griffiths, R. R. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881111420188 · Cited by 895
Self-citationNeural correlates of the LSD experience revealed by multimodal neuroimaging
Carhart-Harris, R. L., Muthukumaraswamy, S., Roseman, L., Kaelen, M., Droog, W., Murphy, K., Tagliazucchi, E., Schenberg, E. E., Nest, T., Orban, C., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1518377113 · Cited by 859 · cited 5×
“This effect is illustrated in Figure 3, a circular connectogram showing how connectivity is primarily between local regions in the placebo condition, but has expanded outward after psilocybin to include more global connectivity with many other brain areas.(59) If we follow Stam’s hypothesis,(49) discussed earlier, dis…”
BackgroundInfluentialSelf-citationRothenberg, M. E. (1998) · New England Journal of Medicine · doi:10.1056/nejm199805283382206 · Cited by 834
Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder
Moreno, F. A., Wiegand, C. B., Taitano, E. K., & Delgado, P. L. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n1110 · Cited by 789
Gasser, P., Holstein, D., Michel, Y., Doblin, R., Yazar-Klosinski, B., Passie, T., & Brenneisen, R. (2014) · Journal of Nervous & Mental Disease · doi:10.1097/nmd.0000000000000113 · Cited by 750
Criticality in Large-Scale Brain fMRI Dynamics Unveiled by a Novel Point Process Analysis
Tagliazucchi, E., Balenzuela, P., Fraiman, D., & Chialvo, D. R. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00015 · Cited by 735
Long-term follow-up of psilocybin-facilitated smoking cessation
Johnson, M. W., Garcia-Romeu, A., & Griffiths, R. R. (2017) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952990.2016.1170135 · Cited by 696
Self-citationHomological scaffolds of brain functional networks
Petri, G., Expert, P., Turkheimer, F., Carhart-Harris, R., Nutt, D., Hellyer, P. J., & Vaccarino, F. (2014) · Journal of The Royal Society Interface · doi:10.1098/rsif.2014.0873 · Cited by 675
Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin
Barrett, F. S., Johnson, M. W., & Griffiths, R. R. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115609019 · Cited by 637
Self-citationLysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials
Krebs, T. S., & Johansen, P.-Ø. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112439253 · Cited by 583
Spike avalanches in vivo suggest a driven, slightly subcritical brain state
Priesemann, V. (2014) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2014.00108 · Cited by 563
Osório, F. D. L., Sanches, R. F., Macedo, L. R., dos Santos, R. G., Maia-de-Oliveira, J. P., Wichert-Ana, L., de Araujo, D. B., Riba, J., Crippa, J. A., & Hallak, J. E. (2015) · Revista Brasileira de Psiquiatria · doi:10.1590/1516-4446-2014-1496 · Cited by 488
Psilocybin-Occasioned mystical experiences in the treatment of tobacco addiction.
Garcia-Romeu, A., Griffiths, R., & Johnson, M. (2015) · Current Drug Abuse Reviews · doi:10.2174/1874473708666150107121331 · Cited by 476
Self-citationGasser, P., Kirchner, K., & Passie, T. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114555249 · Cited by 456
Dynamic Resting-State Functional Connectivity in Major Depression
Kaiser, R. H., Whitfield-Gabrieli, S., Dillon, D. G., Goer, F., Beltzer, M., Minkel, J., Smoski, M., Dichter, G., & Pizzagalli, D. A. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.352 · Cited by 438
Stuck in a rut: rethinking depression and its treatment
Holtzheimer, P. E., & Mayberg, H. S. (2011) · Trends in Neurosciences · doi:10.1016/j.tins.2010.10.004 · Cited by 430
A Dialogue between the Immune System and Brain, Spoken in the Language of Serotonin
Baganz, N. L., & Blakely, R. D. (2013) · ACS Chemical Neuroscience · doi:10.1021/cn300186b · Cited by 309
Roseman, L., Leech, R., Feilding, A., Nutt, D. J., & Carhart-Harris, R. L. (2014) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2014.00204 · Cited by 272
Pathophysiological Role of Neuroinflammation in Neurodegenerative Diseases and Psychiatric Disorders
Hong, H., Kim, B. S., & Im, H.-I. (2016) · International Neurourology Journal · doi:10.5213/inj.1632604.302 · Cited by 258
Carhart-Harris, R. L., Leech, R., Williams, T. M., Erritzoe, D., Abbasi, N., Bargiotas, T., Hobden, P., Sharp, D. J., Evans, J., Feilding, A., et al. (2012) · British Journal of Psychiatry · doi:10.1192/bjp.bp.111.103309 · Cited by 237
Puig, M. V. (2004) · Cerebral Cortex · doi:10.1093/cercor/bhh104 · Cited by 231
Béïque, J.-C., Imad, M., Mladenovic, L., Gingrich, J. A., & Andrade, R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700436104 · Cited by 229
Assessment of addiction severity among ritual users of ayahuasca.
Fábregas, J. M., González, D., Fondevila, S., Cutchet, M., Fernández, X., Barbosa, P. C. R., Alcázar-Córcoles, M. Á., Barbanoj, M. J., Riba, J., & Bouso, J. C. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.03.024 · Cited by 227
Hu, Y., Salmeron, B. J., Gu, H., Stein, E. A., & Yang, Y. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.1 · Cited by 210
Yu, B., Becnel, J., Zerfaoui, M., Rohatgi, R., Boulares, A. H., & Nichols, C. D. (2008) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.143461 · Cited by 210
Self-citationSerotonin 5-HT2A Receptor Activation Blocks TNF-α Mediated Inflammation In Vivo
Nau, F., Yu, B., Martin, D., & Nichols, C. D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075426 · Cited by 198
Self-citationMolecular pathology of allergic disease
Hamid, Q. A., & Minshall, E. M. (2000) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(00)90172-6 · Cited by 196
Neuroimmune signaling: a key component of alcohol abuse
Mayfield, J., Ferguson, L., & Harris, R. A. (2013) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2013.01.024 · Cited by 193
Examining the role of neuroinflammation in major depression
Furtado, M., & Katzman, M. A. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.06.009 · Cited by 192
Immunomodulatory Effects Mediated by Serotonin
Arreola, R., Becerril-Villanueva, E., Cruz-Fuentes, C., Velasco-Velázquez, M. A., Garcés-Alvarez, M. E., Hurtado-Alvarado, G., Quintero-Fabian, S., & Pavón, L. (2015) · Journal of Immunology Research · doi:10.1155/2015/354957 · Cited by 186
Resting‐state functional connectivity and nicotine addiction: prospects for biomarker development
Fedota, J. R., & Stein, E. A. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12882 · Cited by 164
The DTI connectivity of the human claustrum
Torgerson, C. M., Andrei Irimia, A., Goh, S. Y. M., & Horn, J. D. V. (2014) · Human Brain Mapping · doi:10.1002/hbm.22667 · Cited by 157
(1969) · PubMed · Cited by 150
The Varieties of Psychedelic Experience
BLUM, R. H., Masters, R. E. L., & Houston, J. (1967) · The Journal of Criminal Law Criminology and Police Science · doi:10.2307/1141632 · Cited by 150
Residential Psychedelic (LSD) Therapy for the Narcotic Addict: A Controlled Study
Savage, C. (1973) · Archives of General Psychiatry · doi:10.1001/archpsyc.1973.01750360040005 · Cited by 148
Self-similar correlation function in brain resting-state functional magnetic resonance imaging
Expert, P., Lambiotte, R., Chialvo, D. R., Christensen, K., Jensen, H. J., Sharp, D. J., & Turkheimer, F. (2010) · Journal of The Royal Society Interface · doi:10.1098/rsif.2010.0416 · Cited by 140
Cui, H., Zhang, J., Liu, Y., Li, Q., Li, H., Zhang, L., Hu, Q., Cheng, W., Luo, Q., Li, J., et al. (2016) · Human Brain Mapping · doi:10.1002/hbm.23113 · Cited by 123
Poil, S., van Ooyen, A., & Linkenkaer‐Hansen, K. (2008) · Human Brain Mapping · doi:10.1002/hbm.20590 · Cited by 118
Use of d-Lysergic Acid Diethylamide in the Treatment of Alcoholism
Chwelos, N., Blewett, D. B., Smith, C. M., & Hoffer, A. (1959) · Quarterly Journal of Studies on Alcohol · doi:10.15288/qjsa.1959.20.577 · Cited by 111 · cited 1×
“In the 1950s researchers in Saskatchewan, Canada, led by Humphry Osmond and Abram Hoffer were the first to study addiction treatment with psychedelics, specifically using LSD and mescaline to treat alcoholism.(15) Guided by the observation that alcoholics tended to achieve sobriety after experiencing delirium tremens…”
Background‘Hitting Highs at Rock Bottom’: LSD Treatment for Alcoholism, 1950–1970
Dyck, E. (2006) · Social History of Medicine · doi:10.1093/shm/hkl039 · Cited by 102
Yuan, H., Ding, L., Zhu, M., Zotev, V. S., Phillips, R., & Bodurka, J. (2015) · Brain Connectivity · doi:10.1089/brain.2014.0336 · Cited by 101
Serotonin 5-HT 2 receptor activation prevents allergic asthma in a mouse model
Nau, F., Miller, J. R., Saravia, J., Ahlert, T. A., Yu, B., Happel, K. I., Cormier, S. A., & Nichols, C. D. (2014) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00138.2013 · Cited by 97
Self-citationThe Peak Experience Variable in DPT-Assisted Psychotherapy with Cancer Patients
Richards, W. A., Rhead, J., Dileo, F., Yensen, R., & Kurland, A. (1977) · Journal of Psychedelic Drugs · doi:10.1080/02791072.1977.10472020 · Cited by 97
Martin, D. A., & Nichols, C. D. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.08.049 · Cited by 94
Self-citationPhilippi, C. L., Motzkin, J. C., Pujara, M. S., & Koenigs, M. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2015.10.005 · Cited by 93
Li, C., Chen, L., Tu, P., Wang, S.-J., Chen, M.-H., Su, T., & Hsieh, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070089 · Cited by 88
Altinay, M. I., Hulvershorn, L. A., Karne, H. S., Beall, E. B., & Anand, A. (2015) · Brain Connectivity · doi:10.1089/brain.2015.0396 · Cited by 87
Synaptic Plasticity Enables Adaptive Self-Tuning Critical Networks
Stepp, N. D., Plenz, D., & Srinivasa, N. (2015) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1004043 · Cited by 71
Abnormal functional global and local brain connectivity in female patients with anorexia nervosa
Geisler, D., Borchardt, V., Lord, A. R., Boehm, I., Ritschel, F., Zwipp, J., Clas, S., King, J. A., Wolff-Stephan, S., Roessner, V., et al. (2016) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.140310 · Cited by 62
Claustrum projections to prefrontal cortex in the capuchin monkey (Cebus apella)
Reser, D. H., Richardson, K. E., Montibeller, M. O., Zhao, S., Chan, J. M., Soares, J. G. M., Chaplin, T. A., Gattass, R., & Rosa, M. G. P. (2014) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2014.00123 · Cited by 54
Psychedelic Therapy (Utilizing LSD) with Cancer Patients
Pahnke, W. N., Kurland, A. A., Unger, S. M., Savage, C., Wolf, S., & Goodman, L. E. (1970) · Journal of Psychedelic Drugs · doi:10.1080/02791072.1970.10471363 · Cited by 45
Du, M., Liao, W., Lui, S., Huang, X., Li, F. Y., Kuang, W., Li, J., Chen, H.-F., Kendrick, K. M., & Gong, Q. (2015) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nsv040 · Cited by 38
Extracting functionally feedforward networks from a population of spiking neurons
Vincent, K. F., Tauskela, J. S., & Thivierge, J. (2012) · Frontiers in Computational Neuroscience · doi:10.3389/fncom.2012.00086 · Cited by 24
Coutinho, J. F. P., Gonçalves, Ó. F., Soares, J. M., Marques, P., & Sampaio, A. (2016) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2016.08.007 · Cited by 24
Nishiyama, T. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.03.041 · Cited by 20
Resting functional connectivity in social anxiety disorder and the effect of pharmacotherapy
Doruyter, A., Lochner, C., Jordaan, G. P., Stein, D. J., Dupont, P., & Warwick, J. M. (2016) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2016.04.009 · Cited by 16
Role of Monoclonal Antibodies in the Treatment of Asthma
O’Byrne, P. M. (2013) · Canadian Respiratory Journal · doi:10.1155/2013/183948 · Cited by 15
Cited by
Psychedelics promote structural and functional neural plasticity
Ly, C., Greb, A. C., Cameron, L. P., Wong, J. M., Barragan, E. V., Wilson, P. C., Burbach, K. F., Soltanzadeh Zarandi, S., Sood, A., Paddy, M. R., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.05.022 · Cited by 1,207
Predicting responses to psychedelics: a prospective study
Haijen, E. C. H. M., Kaelen, M., Roseman, L., Timmermann, C., Kettner, H., Russ, S., Nutt, D., Daws, R. E., Hampshire, A. D. G., Lorenz, R., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00897 · Cited by 417
Johnson, M. W., Griffiths, R. R., Hendricks, P. S., & Henningfield, J. E. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.05.012 · Cited by 354
Self-citationThe subjective effects of psychedelics may not be necessary for their enduring therapeutic effects
Olson, D. E. (2021) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.0c00192 · Cited by 329
Psychedelics, mystical experience, and therapeutic efficacy: a systematic review
Ko, K., Knight, G., Rucker, J. J., & Cleare, A. J. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.917199 · Cited by 306
Metadata
- Authors
- Nichols, D., Johnson, M., & Nichols, C.
- Venue
- Clinical Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2016-12-26
- Volume
- 101
- Issue
- 2
- Pages
- 209-219
- ISSN
- 0009-9236 (ISSN-L)
- 1532-6535
- OpenAlex
- W2547918114
- Cited by
- 370
- References
- 74
- FWCI
- 24.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.